Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19
Inflammopharmacology · 2024
DOI: 10.1007/s10787-024-01457-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Seyma Oncu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, 03030, Turkey. dr.seymaoncu@gmail.com. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Drug Treatment, COVID-19 Vaccines, Chloroquine. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Afyonkarahisar Health Science University.
Abstract (Originalsprache)
Purpose
Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide and caused mortality. Many factors have been reported to affect the prognosis of COVID-19. In this study, we aimed to investigate the effects of drug therapy and vaccination on prognosis in patients hospitalized with a COVID-19 diagnosis.
Methods
In this single-center, cross-sectional study, data were retrospectively collected from patients receiving inpatient treatment at a university hospital with a diagnosis of COVID-19 between January 1, 2020, and April 30, 2022. The patients’ demographic and clinical characteristics were recorded. The Chi-square, Cox and logistic regression was performed, P < 0.05 was considered statistically significant.
Results
Total 1723 patients (50.1% were men, mean age: 60.6 ± 16.90) who had not been vaccinated rate was 27.0% (> 3 doses: 45.7%). Mortality rate was 17.0%. Increasing age, male, a high Charlson Comorbidity Index (CCI), and no vaccination significantly increased mortality ( P < 0.05). The mortality rate was significantly lower in the chloroquine treatment group than in the other treatment groups. Increasing age, male, and a high CCI were determined to be factors that significantly increased the length of hospital stay (LOHS). LOHS found to be significantly lower in the favipiravir or chloroquine groups compared to the remaining treatment groups ( P < 0.001). Both mortality and the LOHS significantly differed according to AST, d-dimer, ferritin, and GFR.
Conclusion
This study primarily investigated the effect of treatment and vaccination on the prognosis of COVID-19. This was determined to be prepared for another potential pandemic that may arise due to COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, 03030, Turkey. dr.seymaoncu@gmail.com.
- Department of Infectious Disease, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Förderung
- Afyonkarahisar Health Science University
Zitieren
APA
Oncu, S., & Korkmaz, D. (2024). Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01457-4
Vancouver
Oncu S, Korkmaz D. Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01457-4
BibTeX
@article{Oncu2024,
author = {Oncu, Seyma and Korkmaz, Derya},
title = {Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19},
journal = {Inflammopharmacology},
year = {2024},
doi = {10.1007/s10787-024-01457-4}
}
EUVIMED